RhBMP-2 has adverse effects on human oral carcinoma cell lines in vivo

Laryngoscope

Volumn 122, Issue 1, 2012, Pages 95-102

  Kokorina, Natalia A ^a   Lewis, James S ^a   Zakharkin, Stanislav O ^b   Krebsbach, Paul H ^c   Nussenbaum, Brian ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Department of Science and Technology ^*  (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Bone morphogenetic protein; oral cancer; squamous cell carcinoma

Indexed keywords

BETA CATENIN; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; JANUS KINASE; PHOSPHOTRANSFERASE; PROTEIN KINASE; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; STAT PROTEIN; WNT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; GENE EXPRESSION; GENE SEQUENCE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MOUSE; MOUTH CARCINOMA; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TUMOR XENOGRAFT;

ANIMALS; BONE MORPHOGENETIC PROTEIN 2; CARCINOMA, SQUAMOUS CELL; HUMANS; MICE; MOUTH NEOPLASMS; NEOPLASM TRANSPLANTATION; RECOMBINANT PROTEINS; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 84355161664     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1002/lary.22345     Document Type: Article

References (38)

1. Schliephake H,. Bone growth factors in maxillofacial skeletal reconstruction. Int J Oral Maxillofac Surg 2002; 31: 469-484.
2. Burkus JK, Gornet MF, Dickman CA, et al. Anterior lumbar interbody fusion using rhBMP-2 with tapered interbody cages. J Spinal Disord Tech 2002; 15: 337-349.
3. Friedlaender GE, Perry CR, Cole JD, et al. Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg 2001; 83 (suppl 1): 151-158.
4. INFUSE Bone Graft [package insert]. Available at:. Memphis, TN: Medtronic Sofamor Danek USA, Inc.; 2008.
5. Nussenbaum B, Krebsbach PH,. Practical matters in the application of tissue engineered products for skeletal regeneration in the head and neck region. In:, Sandell LJ, Grodzinsky AJ, eds. Tissue Engineering in Musculoskeletal Clinical Practice. Rosemont, IL: American Academy of Orthopedic Surgeons; 2004: 151-159.
6. Thawani JP, Wang AC, Than KD, et al. Bone morphogenetic proteins and cancer: review of the literature. Neurosurgery 2010; 66: 233-246.
7. Poynton AR, Lane JM,. Safety profile for the clinical use of bone morphogenetic proteins in the spine. Spine 2002; 27 (16 suppl 1): S40-S48.
8. Golden JD, Jones AL, Bucholz RW, et al. Recombinant human BMP-2 and allograft compared with autogenous bone graft for reconstruction of diaphyseal tibial fractures with cortical defects [letter]. J Bone Joint Surg 2008; 90: 1168-1169.
9. Gao Q, Tong W, Luria JS, Wang Z, Nussenbaum B, Krebsbach PH,. Effects of bone morphogenetic protein-2 on proliferation and angiogenesis in oral squamous cell carcinoma. Int J Oral Maxillofac Surg 2010; 39: 266-271.
10. Jin Y, Tipoe GL, Liong EC, Lau TY, Fung PC, Leung KM,. Overexpression of BMP-2/4, -5 and BMPR-1A is associated with malignancy of oral epithelium. Oral Oncology 2001; 37: 225-233. (Pubitemid 32245846)
11. Hanahan D, Weinberg RA,. The hallmarks of cancer. Cell 2000; 100: 57-70. (Pubitemid 30046295)
12. Zhou X, Temam S, Oh M, et al. Global expression-based classification of lymph node metastasis and extracapsular spread of oral tongue squamous cell carcinoma. Neoplasia 2006; 8: 925-932. (Pubitemid 44706242)
13. Willette RN, Gu JL, Lysko PG, et al. BMP-2 gene expression and effects on human vascular smooth muscle cells. J Vasc Res 1999; 36: 120-125. (Pubitemid 29210918)
14. Gobbi G, Sangiorgi L, Lenzi L, et al. Seven BMPs and all their receptors are simultaneously expressed in osteosarcoma cells. Int J Oncol 2002; 20: 143-147.
15. Valcourt U, Gouttenoire J, Moustakas A, et al. Functions of transforming growth factor-beta family type I receptors and Smad proteins in the hypertrophic maturation and osteoblastic differentiation of chondrocytes. J Biol Chem 2002; 277: 33545-33558.
16. Bau B, Haag J, Schmid E, et al. Bone morphogenetic protein-mediating receptor-associated Smads as well as common Smad are expressed in human articular chondrocytes but not up-regulated or down-regulated in osteoarthritic cartilage. J Bone Miner Res 2002; 17: 2141-2150. (Pubitemid 35416749)
17. Sebestyen A, Barna G, Nagy K, et al. Smad signal and TGFbeta induced apoptosis in human lymphoma cells. Cytokine 2005; 30: 228-235. (Pubitemid 40775840)
18. Simic P, Culej JB, Orlic I, et al. Systemically administered bone morphogenetic protein-6 restores bone in aged ovariectomized rats by increasing bone formation and suppressing bone resorption. J Biol Chem 2006; 281: 25509-22521.
19. Sun J, Wei L, Liu X, et al. Influences of ionic dissolution products of dicalcium silicate coating on osteoblastic proliferation, differentiation and gene expression. Acta Biomater 2009; 5: 1284-1293.
20. Myers JN, Holsinger FC, Jasser SA, et al. An orthotopic nude mouse model of oral tongue squamous cell carcinoma. Clin Cancer Res 2002; 8: 293-298. (Pubitemid 34101491)
21. Soares AF, Xavier RL, daCosta Miguel MC, et al. Bone morphogenetic protein-2/4 and bone morphogenetic protein receptor type IA expression in metastatic and nonmetastatic oral squamous cell carcinoma. Am J Otolaryngol 2010; 31: 266-271.
22. Kupferman ME, Myers JN,. Molecular biology of oral cavity squamous cell carcinoma. Otolaryngol Clin North Am 2006; 39: 229-247.
23. Brandwein-Gensler M, Teixeira MS, Lewis CM, et al. Oral squamous cell carcinoma: histologic risk assessment, but not margin status, is strongly predictive of local disease-free and overall survival. Am J Surg Pathol 2005; 29: 167-178. (Pubitemid 40170634)
24. Park KS, Gumbiner BM,. Cadherin 6B induces BMP signaling and de-epithelialization during the epithelial mesenchymal transition of the neural crest. Development 2010; 137: 2691-2701.
25. Townsend TA, Robinson JY, Deig CR, et al. BMP-2 and TGFβ2 shared pathways regulate endocardial cell transformation. Cells Tissues Organs 2011; 194: 1-12.
26. Yan C, Grimm WA, Garner WL, et al. Epithelial to mesenchymal transition in human skin wound healing is induced by tumor necrosis factor-α through bone morphogenetic protein-2. Am J Surg Pathol 2010; 176: 2247-2258.
27. Kang MH, Kim JS, Seo JS, et al. BMP2 accelerates the motility and invasiveness of gastric cancer cells via activation of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway. Exp Cell Res 2010; 316: 24-37.
28. Kang MH, Kang HN, Kim JL, et al. Inhibition of PI3 kinase/Akt pathway is required for BMP2-induced EMT and invasion. Oncol Rep 2009; 22: 525-534.
29. Zhang M, Yan Y, Lim YB, et al. BMP-2 modulates β-catenin signaling through stimulation of Lrp5 expression and inhibition of β-TrCP expression in osteoblasts. J Cell Biochem 2009; 108: 896-905.
30. Molinolo AA, Amornphimoltham P, Squarize CH, et al. Dysregulated molecular networks in head and neck carcinogenesis. Oral Oncol 2009; 45: 324-334.
31. Yang F, Zeng Q, Yu G, et al. Wnt/β-catenin signaling inhibits death receptor-mediated apoptosis and promotes invasive growth of HNSCC. Cell Signal 2006; 18: 679-687. (Pubitemid 43113298)
32. Odajima T, Sasaki Y, Tanaka N, et al. Abnormal β-catenin expression in oral cancer with no gene mutation: correlation with expression of cyclin D1 and epidermal growth factor receptor, Ki-67labeling index, and clinicopathological features. Hum Pathol 2005; 36: 234-241. (Pubitemid 40404006)
33. Zheng Z, Pan J, Chu B, et al. Downregulation and abnormal expression of E-cadherin and β-catenin in nasopharyngeal carcinoma: close association with advanced disease stage and lymph node metastasis. Hum Pathol 1999; 30: 458-466. (Pubitemid 29177827)
34. Liu LK, Jiang XY, Zhou XX, et al. Upregulation of vimentin and aberrant expression of E-cadherin/β-catenin complex in oral squamous cell carcinomas: correlation with the clinicopathological features and patient outcome. Mod Pathol 2010; 23: 213-224.
35. Leeman RJ, Lui VW, Grandis JR,. STAT3 as a therapeutic target in head and neck cancer. Expert Opin Biol Ther 2006; 6: 231-241. (Pubitemid 43344743)
36. Wheeler SE, Suzuki S, Thomas SM, et al. Epidermal growth factor receptor variant III mediates head and neck cancer cell invasion via STAT3 activation. Oncogene 2010; 29: 5135-5145.
37. Levy O, Ruvinov E, Reem T, et al. Highly efficient osteogenic differentiation of human mesenchymal stem cells by eradication of STAT3 signaling. Int J Biochem Cell Biol 2010; 42: 1823-1830.
38. Mikami Y, Asano M, Honda MJ, Takagi M,. Bone morphogenetic protein 2 and dexamethasone synergistically increase alkaline phosphatase levels through JAK/STAT signaling in C3H10T1/2 cells. J Cell Physiol 2010; 223: 123-133.